GRAIL announces positive top-line results from Galleri PATHFINDER 2 study: Menlo Park, California Saturday, June 21, 2025, 18:00 Hrs [IST] GRAIL, Inc, a healthcare company whose m ...

PCI asks institutions to submit appeal regarding statutory documents for AY25-26: Gireesh Babu, New Delhi Saturday, June 21, ...

KARL STORZ US gets expanded indication for Solo+ Tympanostomy tube device to use in pediatric patients aged 6 to 24 months old: El Segundo, California Saturday, June 21, 2025, 17: ...

Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...

CereVasc receives Health Canada investigational testing authorization to conduct STRIDE trial to evaluate eShunt System: Boston Saturday, June 21, 2025, 14:00 Hrs [IST] CereVasc I ...

Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent: Wayne, Pennsylvania Saturday, June 21, 2025, 13:00 Hrs [IST] Palvella Therapeutics Inc, a clinical-sta ...

EMA committee recommends marketing approval for Bayer’s Nubeqa for patients with advanced prostate cancer: Berlin Saturday, June 21, 2025, 10:00 Hrs [IST] The Committee for Medi ...

Telangana DCA seizes counterfeit versions of Rosuvas F 20 & Rosuvas F 10 from distributors in Hyderabad: Peethaambaran Kunnathoor, Chennai Saturday, June 21, 2025, 08:00 Hrs [IST] ...

Shardul Nautiyal, Mumbai Saturday, June 21, 2025, 08:00 Hrs [IST] ...

Biogen begins phase 3 paediatric study of Omaveloxolone to treat Friedreich ataxia: Cambridge, Mass Saturday, June 21, 2025, 11:00 Hrs [IST] Biogen Inc, a leading biotechnology co ...

TN PTA to organise protest meeting on June 25 against OTC policy & e-pharmacy: Peethaambaran Kunnathoor, Chennai Saturday, June 21, 2025, 08:00 Hrs [IST] The chairman of the Tamil ...

Sanofi & Regeneron’s Dupixent receives US FDA approval to treat patients with bullous pemphigoid: Paris Saturday, June 21, 2025, 12:00 Hrs [IST] The US Food and Drug Administrat ...